Bank of America’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.7M | Buy |
866,061
+65,884
| +8% | +$1.22M | ﹤0.01% | 2449 |
|
|
2025
Q4 | $11M | Sell |
800,177
-4,783
| -0.6% | -$74.5K | ﹤0.01% | 2781 |
|
|
2025
Q3 | $14.2M | Buy |
804,960
+21,424
| +3% | +$339K | ﹤0.01% | 2940 |
|
|
2025
Q2 | $11.8M | Buy |
783,536
+5,775
| +0.7% | +$95.8K | ﹤0.01% | 3084 |
|
|
2025
Q1 | $12.5M | Sell |
777,761
-10,693
| -1% | -$199K | ﹤0.01% | 2913 |
|
|
2024
Q4 | $13.7M | Buy |
788,454
+2,884
| +0.4% | +$50.8K | ﹤0.01% | 2627 |
|
|
2024
Q3 | $13.8M | Buy |
785,570
+2,986
| +0.4% | +$50.9K | ﹤0.01% | 2760 |
|
|
2024
Q2 | $8.76M | Buy |
782,584
+3,032
| +0.4% | +$28.6K | ﹤0.01% | 3067 |
|
|
2024
Q1 | $6.79M | Sell |
779,552
-21,789
| -3% | -$200K | ﹤0.01% | 3344 |
|
|
2023
Q4 | $9.81M | Buy |
801,341
+9,371
| +1% | +$64.9K | ﹤0.01% | 2916 |
|
|
2023
Q3 | $3.19M | Buy |
791,970
+9,463
| +1% | +$58.8K | ﹤0.01% | 3819 |
|
|
2023
Q2 | $5.63M | Buy |
782,507
+9,773
| +1% | +$62.4K | ﹤0.01% | 3287 |
|
|
2023
Q1 | $2.6M | Buy |
772,734
+3,994
| +0.5% | +$12K | ﹤0.01% | 4114 |
|
|
2022
Q4 | $2.13M | Sell |
768,740
-558
| -0.1% | -$1.25K | ﹤0.01% | 4200 |
|
|
2022
Q3 | $1.77M | Buy |
769,298
+195
| +0% | +$317 | ﹤0.01% | 4389 |
|
|
2022
Q2 | $1.18M | Sell |
769,103
-51,287
| -6% | -$129K | ﹤0.01% | 4775 |
|
|
2022
Q1 | $3.99M | Buy |
820,390
+39,645
| +5% | +$324K | ﹤0.01% | 3872 |
|
|
2021
Q4 | $11.6M | Buy |
780,745
+5,788
| +0.7% | +$115K | ﹤0.01% | 2772 |
|
|
2021
Q3 | $16.7M | Buy |
774,957
+758,622
| +4,644% | +$16.3M | ﹤0.01% | 2329 |
|
|
2021
Q2 | $268K | Sell |
16,335
-18,565
| -53% | -$353K | ﹤0.01% | 5875 |
|
|
2021
Q1 | $826K | Buy |
34,900
+15,890
| +84% | +$475K | ﹤0.01% | 5006 |
|
|
2020
Q4 | $453K | Sell |
19,010
-1,292
| -6% | -$20.6K | ﹤0.01% | 5078 |
|
|
2020
Q3 | $239K | Buy |
20,302
+226
| +1% | +$2.43K | ﹤0.01% | 5188 |
|
|
2020
Q2 | $210K | Buy |
20,076
+2,598
| +15% | +$23.4K | ﹤0.01% | 5212 |
|
|
2020
Q1 | $126K | Sell |
17,478
-1,228
| -7% | -$12.7K | ﹤0.01% | 5392 |
|
|
2019
Q4 | $250K | Sell |
18,706
-865
| -4% | -$12.3K | ﹤0.01% | 5482 |
|
|
2019
Q3 | $302K | Buy |
19,571
+544
| +3% | +$7.07K | ﹤0.01% | 5411 |
|
|
2019
Q2 | $251K | Buy |
19,027
+2,714
| +17% | +$37K | ﹤0.01% | 5507 |
|
|
2019
Q1 | $287K | Sell |
16,313
-4,406
| -21% | -$69.1K | ﹤0.01% | 5339 |
|
|
2018
Q4 | $237K | Sell |
20,719
-2,363
| -10% | -$28.6K | ﹤0.01% | 5414 |
|
|
2018
Q3 | $328K | Buy |
23,082
+6,981
| +43% | +$99.2K | ﹤0.01% | 5217 |
|
|
2018
Q2 | $244K | Buy |
16,101
+13,899
| +631% | +$235K | ﹤0.01% | 5298 |
|
|
2018
Q1 | $29K | Buy |
2,202
+1,020
| +86% | +$19.4K | ﹤0.01% | 6252 |
|
|
2017
Q4 | $28K | Buy |
1,182
+655
| +124% | +$15.5K | ﹤0.01% | 6304 |
|
|
2017
Q3 | $10K | Buy |
527
+413
| +362% | +$9.38K | ﹤0.01% | 6547 |
|
|
2017
Q2 | $3K | Sell |
114
-1,211
| -91% | -$33.3K | ﹤0.01% | 6679 |
|
|
2017
Q1 | $27K | Buy |
1,325
+75
| +6% | +$1.02K | ﹤0.01% | 6194 |
|
|
2016
Q4 | $8K | Sell |
1,250
-2,500
| -67% | -$14.8K | ﹤0.01% | 6608 |
|
|
2016
Q3 | $24K | Buy |
+3,750
| New | +$19.1K | ﹤0.01% | 6054 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
Bank of America's PLSE Position: Q1 2026 in Review
Bank of America increased its Pulse Biosciences (PLSE) stake by 8.2% in Q1 2026, buying an estimated $1.22M and bringing the position to 866,061 shares worth $18.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.
Bank of America first reported a position in PLSE in Q3 2016 and has held it in 39 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Bank of America held 866,061 shares of Pulse Biosciences worth $18.7M as of Q1 2026.
- Bank of America bought 65,884 Pulse Biosciences shares in Q1 2026, an estimated $1.22M.
- Pulse Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2449 holding.
- Bank of America first reported a position in Pulse Biosciences in Q3 2016 and has held it in 39 quarters since.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.